Home › Ovarian Cancer › NCT06518746
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Who can join
Up to age 30 · All sexes
Full eligibility criteria
Inclusion Criteria: * \< 30 years of age * Individuals diagnosed with a disorder of sex development who have any risk for malignancy in their gonadal tissue and will have their gonads removed for a clinical indication * Individuals diagnosed with a disorder of sex development who are at risk of primary ovarian insufficiency (POI) due to an underlying genetic condition Exclusion Criteria: * Pregnancy * Patients likely to retain inherent fertility and reproductive function * Patients deemed high risk for perioperative complications * Patients 7-17 years of age unable to provide assent (i.e. significant psychiatric problems/cognitive delay) * Patients 18 and older unable to provide consent (i.e. significant psychiatric problems/cognitive delay)
About the study
The "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignancy and a high risk of infertility or sterility. For these patients, experimental gonadal tissue cryopreservation is the only fertility preservation option available. The overall objective of this study is to determine the safety and efficacy of gonadal tissue cryopreservation as a method of preserving fertility and/or restoring hormonal function in patients with gonadal dysgenesis who are at risk of decreased fertility potential or malignancy.
What is being tested
- Cryopreservation of gonadal tissue (other)
Sponsor: University of Colorado, Denver · Participants: 50 · Started: Aug 16, 2021
Contact the study team
- Kristine Corkum, MD · Phone: (720) 777-6174
- Jocelyn Phipers · Phone: 303-724-7807
Official record on ClinicalTrials.gov — NCT06518746
Locations in the U.S.
| Colorado | University of Colorado, Aurora |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.